Global Non-steroidal Anti-inflammatory Drugs(NSAID) Professional Survey Report 2023, Forecast to 2028

Publisher Name :
Date: 14-Dec-2023
No. of pages: 106

Non-steroidal anti-inflammatory drugs is a class of analgesic medication that reduces pain, fever and inflammation. Since most episodes of back pain involve inflammation, NSAIDs such as ibuprofen and naproxen are often an effective treatment option.

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.

Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.

Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.

2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.

But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China's reopening could provide a much-needed and timely boost.

The report researches and analyzes the influence of the Non-steroidal Anti-inflammatory Drugs?NSAID? industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.

Market Segment by Product Type

- Aspirin

- Ibuprofen

- Naproxen

- Nabumetone

- Others

Market Segment by Product Application

- Back Pain Treatment

- Osteoarthritis Treatment

- Others

Finally, the report provides detailed profile and data information analysis of leading company.

- Bayer

- Merck Sharp & Dohme

- Pfizer

- Novacap

- Kopran

- Abbott

- Glaxo Smith Kline

- Perrigo Company

- Geri-Care Pharmaceuticals

- Sun Pharmaceutical Industries

- Reddy Pharmaceuticals

- Johnson & Johnson

Insights and Tools:

We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.

The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.

The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.

Research Objectives

- 1.To study and analyze the global Non-steroidal Anti-inflammatory Drugs?NSAID? consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.

- 2.To understand the structure of Non-steroidal Anti-inflammatory Drugs?NSAID? market by identifying its various subsegments.

- 3.Focuses on the key global Non-steroidal Anti-inflammatory Drugs?NSAID? manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.

- 4.To analyze the Non-steroidal Anti-inflammatory Drugs?NSAID? with respect to individual growth trends, future prospects, and their contribution to the total market.

- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- 6.To project the consumption of Non-steroidal Anti-inflammatory Drugs?NSAID? submarkets, with respect to key regions (along with their respective key countries).

- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- 8.To strategically profile the key players and comprehensively analyze their growth strategies.

Global Non-steroidal Anti-inflammatory Drugs(NSAID) Professional Survey Report 2023, Forecast to 2028

Table of Contents

Global Non-steroidal Anti-inflammatory Drugs?NSAID? Professional Survey Report Report 2023, Forecast to 2028

1 Market Study Overview
1.1 Study Objectives
1.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Non-steroidal Anti-inflammatory Drugs?NSAID? Segment by Type
2.1.1 Aspirin
2.1.2 Ibuprofen
2.1.3 Naproxen
2.1.4 Nabumetone
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Back Pain Treatment
2.2.2 Osteoarthritis Treatment
2.2.3 Others
2.3 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Comparison by Regions (2018-2028)
2.3.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size (2018-2028)
2.3.2 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Status and Prospect (2018-2028)
2.3.3 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Status and Prospect (2018-2028)
2.3.4 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Status and Prospect (2018-2028)
2.3.5 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Status and Prospect (2018-2028)
2.3.6 Middle East & Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Non-steroidal Anti-inflammatory Drugs?NSAID? Industry Impact
2.5.1 Non-steroidal Anti-inflammatory Drugs?NSAID? Business Impact Assessment - Covid-19
2.5.2 Market Trends and Non-steroidal Anti-inflammatory Drugs?NSAID? Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturer Market Share
3.5 Top 10 Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs?NSAID? Market
3.7 Key Manufacturers Non-steroidal Anti-inflammatory Drugs?NSAID? Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Non-steroidal Anti-inflammatory Drugs?NSAID? Industry Key Manufacturers
4.1 Bayer
4.1.1 Company Details
4.1.2 Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.1.3 Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Bayer News
4.2 Merck Sharp & Dohme
4.2.1 Company Details
4.2.2 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.2.3 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Merck Sharp & Dohme News
4.3 Pfizer
4.3.1 Company Details
4.3.2 Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.3.3 Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Pfizer News
4.4 Novacap
4.4.1 Company Details
4.4.2 Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.4.3 Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Novacap News
4.5 Kopran
4.5.1 Company Details
4.5.2 Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.5.3 Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Kopran News
4.6 Abbott
4.6.1 Company Details
4.6.2 Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.6.3 Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Abbott News
4.7 Glaxo Smith Kline
4.7.1 Company Details
4.7.2 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.7.3 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.5 Glaxo Smith Kline News
4.8 Perrigo Company
4.8.1 Company Details
4.8.2 Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.8.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 Perrigo Company News
4.9 Geri-Care Pharmaceuticals
4.9.1 Company Details
4.9.2 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.9.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Geri-Care Pharmaceuticals News
4.10 Sun Pharmaceutical Industries
4.10.1 Company Details
4.10.2 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.10.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 Sun Pharmaceutical Industries News
4.11 Reddy Pharmaceuticals
4.11.1 Company Details
4.11.2 Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.11.3 Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.11.4 Main Business Overview
4.11.5 Reddy Pharmaceuticals News
4.12 Johnson & Johnson
4.12.1 Company Details
4.12.2 Johnson & Johnson Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification
4.12.3 Johnson & Johnson Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.12.4 Main Business Overview
4.12.5 Johnson & Johnson News

5 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Categorized by Regions
5.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue, Sales and Market Share by Regions
5.1.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Regions (2018-2023)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Market Share by Regions (2018-2023)
5.2 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
5.3 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
5.4 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
5.5 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
5.6 Middle East & Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)

6 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size Categorized by Countries
6.1 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Market Share by Countries
6.1.1 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
6.1.2 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
6.1.3 United States Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
6.1.4 Canada Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
6.1.5 Mexico Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
6.2 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Value) by Manufacturers
6.3 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type (2018-2023)
6.4 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2018-2023)

7 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size Categorized by Countries
7.1 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Market Share by Countries
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
7.1.3 Germany Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
7.1.4 UK Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
7.1.5 France Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
7.1.6 Russia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
7.1.7 Italy Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
7.1.8 Spain Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
7.2 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Value) by Manufacturers
7.3 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type (2018-2023)
7.4 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2018-2023)

8 Asia-Pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size Categorized by Countries
8.1 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
8.1.2 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
8.1.3 China Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
8.1.4 South Korea Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
8.1.5 Japan Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
8.1.6 Australia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
8.1.7 India Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
8.1.8 Southeast Asia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
8.2 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Value) by Manufacturers
8.3 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type (2018-2023)
8.4 Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2018-2023)

9 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size Categorized by Countries
9.1 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Market Share by Countries
9.1.1 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
9.1.2 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
9.1.3 Brazil Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
9.2 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type (2018-2023)
9.3 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2018-2023)

10 Middle East and Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size Categorized by Countries
10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
10.1.3 GCC Countries Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
10.1.4 Turkey Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
10.1.5 Egypt Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
10.1.6 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type
10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2018-2023)

11 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Segment by Type
11.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue, Sales and Market Share by Type (2018-2023)
11.1.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type (2018-2023)
11.1.2 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Market Share by Type (2018-2023)
11.2 Aspirin Sales Growth Rate and Price
11.2.1 Global Aspirin Sales Growth Rate (2018-2023)
11.2.2 Global Aspirin Price (2018-2023)
11.3 Ibuprofen Sales Growth Rate and Price
11.3.1 Global Ibuprofen Sales Growth Rate (2018-2023)
11.3.2 Global Ibuprofen Price (2018-2023)
11.4 Naproxen Sales Growth Rate and Price
11.4.1 Global Naproxen Sales Growth Rate (2018-2023)
11.4.2 Global Naproxen Price (2018-2023)
11.5.1 Global Nabumetone Sales Growth Rate (2018-2023)
11.5.2 Global Nabumetone Price (2018-2023)
11.6 Others Sales Growth Rate and Price
11.6.1 Global Others Sales Growth Rate (2018-2023)
11.6.2 Global Others Price (2018-2023)

12 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Segment by Application
12.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2018-2023)
12.2 Back Pain Treatment Sales Growth Rate (2018-2023)
12.3 Osteoarthritis Treatment Sales Growth Rate (2018-2023)
12.4 Others Sales Growth Rate (2018-2023)

13 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast
13.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue, Sales and Growth Rate (2023-2028)
13.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast by Regions (2023-2028)
13.2.1 North America Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast (2023-2028)
13.2.2 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast (2023-2028)
13.2.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast (2023-2028)
13.2.4 South America Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast (2023-2028)
13.2.5 Middle East & Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast (2023-2028)
13.3 Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast by Type (2023-2028)
13.3.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Forecast by Type (2023-2028)
13.3.2 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share Forecast by Type (2023-2028)
13.4 Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast by Application (2023-2028)
13.4.1 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Forecast by Application (2023-2028)
13.4.2 Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share Forecast by Application (2023-2028)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Non-steroidal Anti-inflammatory Drugs?NSAID? Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers


List of Tables and Figures

Figure Product Picture Non-steroidal Anti-inflammatory Drugs?NSAID?
Figure Market Concentration Ratio and Market Maturity Analysis of Non-steroidal Anti-inflammatory Drugs?NSAID?
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size by Type
Figure Global Market Share of Non-steroidal Anti-inflammatory Drugs?NSAID? by Type in 2022
Figure Aspirin Picture
Figure Ibuprofen Picture
Figure Naproxen Picture
Figure Nabumetone Picture
Figure Others Picture
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size (Volume) by Application
Figure Back Pain Treatment Picture
Figure Osteoarthritis Treatment Picture
Figure Others Picture
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Comparison by Regions (M USD) 2018-2028
Figure Global Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size (Million US$) (2018-2028)
Figure North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million US$) Growth Rate (2018-2028)
Figure Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million US$) Growth Rate (2018-2028)
Figure South America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million US$) Growth Rate (2018-2028)
Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Non-steroidal Anti-inflammatory Drugs?NSAID? Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Manufacturer (2018-2023)
Figure Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Manufacturer in 2022
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Manufacturer (2018-2023)
Figure Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Manufacturer in 2022
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs?NSAID? Market
Table Key Manufacturers Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type
Table Mergers & Acquisitions Planning
Table Bayer Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Bayer
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2018-2023
Table Bayer Main Business
Table Bayer Recent Development
Table Merck Sharp & Dohme Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Merck Sharp & Dohme
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck Sharp & Dohme 2018-2023
Table Merck Sharp & Dohme Main Business
Table Merck Sharp & Dohme Recent Development
Table Pfizer Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Pfizer
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2018-2023
Table Pfizer Main Business
Table Pfizer Recent Development
Table Novacap Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Novacap
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novacap 2018-2023
Table Novacap Main Business
Table Novacap Recent Development
Table Kopran Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Kopran
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Kopran 2018-2023
Table Kopran Main Business
Table Kopran Recent Development
Table Abbott Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Abbott
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Abbott 2018-2023
Table Abbott Main Business
Table Abbott Recent Development
Table Glaxo Smith Kline Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Glaxo Smith Kline
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Glaxo Smith Kline 2018-2023
Table Glaxo Smith Kline Main Business
Table Glaxo Smith Kline Recent Development
Table Perrigo Company Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Perrigo Company
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Perrigo Company 2018-2023
Table Perrigo Company Main Business
Table Perrigo Company Recent Development
Table Geri-Care Pharmaceuticals Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Geri-Care Pharmaceuticals
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Geri-Care Pharmaceuticals 2018-2023
Table Geri-Care Pharmaceuticals Main Business
Table Geri-Care Pharmaceuticals Recent Development
Table Sun Pharmaceutical Industries Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Sun Pharmaceutical Industries
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries 2018-2023
Table Sun Pharmaceutical Industries Main Business
Table Sun Pharmaceutical Industries Recent Development
Table Reddy Pharmaceuticals Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Reddy Pharmaceuticals
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Reddy Pharmaceuticals 2018-2023
Table Reddy Pharmaceuticals Main Business
Table Reddy Pharmaceuticals Recent Development
Table Johnson & Johnson Company Profile
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of Johnson & Johnson
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2018-2023
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Non-steroidal Anti-inflammatory Drugs?NSAID? Product Introduction, Application and Specification of
Figure Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2018-2023)
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Regions (2018-2023)
Figure Global Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Regions in 2022
Table Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Regions (2018-2023)
Figure Global Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Regions in 2022
Figure North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure South America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2018-2023)
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries (2018-2023)
Figure North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries in 2022
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2018-2023)
Figure North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries in 2022
Figure United States Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Canada Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Mexico Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Manufacturer (2022)
Figure North America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Manufacturer in 2022
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Type (2018-2023)
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Type (2018-2023)
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Application (2018-2023)
Table North America Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Application (2018-2023)
Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2018-2023)
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries (2018-2023)
Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries in 2022
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2018-2023)
Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries in 2022
Figure Germany Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure UK Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure France Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Russia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Italy Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Spain Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Manufacturer (2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Manufacturer in 2022
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Type (2018-2023)
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Type (2018-2023)
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Application (2018-2023)
Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Application (2018-2023)
Figure Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2018-2023)
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) by Countries (2018-2023)
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries (2018-2023)
Figure Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries in 2022
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2018-2023)
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2018-2023)
Figure Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries in 2022
Figure China Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure South Korea Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Japan Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Australia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure India Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Figure Southeast Asia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2018-2023)
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Manufacturer (2022)
Figure Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Manufacturer in 2022
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Type (2018-2023)
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Type (2018-2023)
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales by Application (2018-2023)
Table Asia-pacific Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Application (2018-2023)
Figure South America Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2018-2023)
Table South America Non-ster
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs